Clinical trial
A Phase II Study of Radiofrequency Ablation of Lung Tumors
NCT00180856 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Radiofrequency Ablation of Lung Tumors
- Lead sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- Not reported
- Enrollment
- 60
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, metastasis